Current Ratio
since 2012
Calculation
Zoetis Inc., current ratio, long-term trends, calculation
| Current ratio | = | Current assets1 | ÷ | Current liabilities1 | |
|---|---|---|---|---|---|
| Dec 31, 2023 | 3.36 | = | 6,343) | ÷ | 1,889) |
| Dec 31, 2022 | 2.37 | = | 7,506) | ÷ | 3,167) |
| Dec 31, 2021 | 3.86 | = | 6,930) | ÷ | 1,797) |
| Dec 31, 2020 | 3.05 | = | 6,611) | ÷ | 2,170) |
| Dec 31, 2019 | 2.63 | = | 4,748) | ÷ | 1,806) |
| Dec 31, 2018 | 3.60 | = | 4,399) | ÷ | 1,223) |
| Dec 31, 2017 | 3.85 | = | 4,217) | ÷ | 1,094) |
| Dec 31, 2016 | 3.03 | = | 3,390) | ÷ | 1,117) |
| Dec 31, 2015 | 2.15 | = | 3,830) | ÷ | 1,781) |
| Dec 31, 2014 | 3.19 | = | 3,465) | ÷ | 1,086) |
| Dec 31, 2013 | 2.37 | = | 3,357) | ÷ | 1,415) |
| Dec 31, 2012 | 2.55 | = | 2,864) | ÷ | 1,123) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).
1 US$ in millions
Comparison to Competitors
Zoetis Inc., current ratio, long-term trends, comparison to competitors
| Zoetis Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Moderna Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2023 | 3.36 | 0.87 | 1.65 | 1.43 | 1.68 | 0.94 | 1.43 | 1.16 | 1.25 | 3.42 | 0.91 | 5.69 | 1.75 |
| Dec 31, 2022 | 2.37 | 0.96 | 1.41 | 1.25 | 1.89 | 1.05 | 1.29 | 0.99 | 1.47 | 2.73 | 1.22 | 5.06 | 1.48 |
| Dec 31, 2021 | 3.86 | 0.79 | 1.59 | 1.52 | 1.43 | 1.23 | 1.27 | 1.35 | 1.27 | 1.76 | 1.40 | 3.56 | 1.50 |
| Dec 31, 2020 | 3.05 | 0.84 | 1.81 | 1.58 | 1.86 | 1.40 | 1.40 | 1.21 | 1.02 | 1.43 | 1.35 | 3.63 | 2.13 |
| Dec 31, 2019 | 2.63 | 3.18 | 1.44 | 1.60 | 5.19 | 1.16 | 3.10 | 1.26 | 1.24 | 7.89 | 0.88 | 3.67 | 1.92 |
| Dec 31, 2018 | 3.60 | 0.98 | 2.79 | 1.61 | 1.47 | 1.73 | 3.38 | 1.47 | 1.17 | 7.02 | 1.57 | 4.47 | 1.73 |
| Dec 31, 2017 | 3.85 | 1.28 | 5.49 | 1.55 | 1.43 | 1.32 | 2.74 | 1.41 | 1.33 | — | 1.35 | 3.82 | 1.34 |
| Dec 31, 2016 | 3.03 | 1.65 | 4.11 | 1.55 | 0.97 | 1.37 | 2.22 | 2.47 | 1.78 | — | 1.25 | 2.56 | 1.44 |
| Dec 31, 2015 | 2.15 | 1.50 | 4.44 | 1.30 | 1.27 | 1.53 | 2.50 | 2.17 | 1.55 | — | 1.49 | 3.59 | 1.38 |
| Dec 31, 2014 | 3.19 | 1.41 | 4.95 | 1.73 | 1.75 | 1.09 | 3.07 | 2.36 | 1.77 | — | 2.67 | 3.31 | 1.22 |
| Dec 31, 2013 | 2.37 | 2.59 | 3.44 | 1.52 | 2.01 | 1.47 | 1.15 | 2.20 | 2.00 | — | 2.41 | 6.01 | 3.16 |
| Dec 31, 2012 | 2.55 | 2.27 | 3.81 | 1.15 | 1.80 | 1.55 | 1.44 | 1.90 | 1.90 | — | 2.15 | 7.37 | 2.31 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Zoetis Inc., current ratio, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Zoetis Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Dec 31, 2023 | 3.36 | 1.26 |
| Dec 31, 2022 | 2.37 | 1.29 |
| Dec 31, 2021 | 3.86 | 1.35 |
| Dec 31, 2020 | 3.05 | 1.35 |
| Dec 31, 2019 | 2.63 | 1.66 |
| Dec 31, 2018 | 3.60 | 1.70 |
| Dec 31, 2017 | 3.85 | 1.73 |
| Dec 31, 2016 | 3.03 | 1.91 |
| Dec 31, 2015 | 2.15 | 1.90 |
| Dec 31, 2014 | 3.19 | 2.18 |
| Dec 31, 2013 | 2.37 | 2.16 |
| Dec 31, 2012 | 2.55 | 2.04 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).
Comparison to Industry (Health Care)
Zoetis Inc., current ratio, long-term trends, comparison to industry (health care)
| Zoetis Inc. | Health Care | |
|---|---|---|
| Dec 31, 2023 | 3.36 | 1.14 |
| Dec 31, 2022 | 2.37 | 1.16 |
| Dec 31, 2021 | 3.86 | 1.21 |
| Dec 31, 2020 | 3.05 | 1.21 |
| Dec 31, 2019 | 2.63 | 1.34 |
| Dec 31, 2018 | 3.60 | 1.38 |
| Dec 31, 2017 | 3.85 | 1.47 |
| Dec 31, 2016 | 3.03 | 1.68 |
| Dec 31, 2015 | 2.15 | 1.67 |
| Dec 31, 2014 | 3.19 | 1.87 |
| Dec 31, 2013 | 2.37 | 1.93 |
| Dec 31, 2012 | 2.55 | 1.81 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).